Many patients taking GLP-1 receptor agonists also use other medications that may affect fluid balance, including diuretics or SGLT2 inhibitors
This dual action can influence appetite, energy metabolism, and blood sugar regulation in potentially different ways than a GLP-1-only drug, which may translate to greater average weight loss for some patients
Glutathione: new candidate neuropeptide in the central nervous system
When to Adjust Dosing Regimens Deciding to change the dose of Vitamin B12 shots depends on lab results and how patients feel
About SURMOUNT-5 SURMOUNT-5 (NCT05822830) was a 72-week, multi-center, randomized, open-label, Phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea (OSA) or cardiovascular disease, who did not have diabetes